pI: 5.9815 |
Length (AA): 410 |
MW (Da): 43585 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
5 | 80 | 2c7h (A) | 9 | 86 | 16.00 | 0 | 0.38 | 0.41 | -0.83 |
302 | 410 | 1wgm (A) | 2 | 96 | 18.00 | 0 | 1 | 0.27 | 0.46 |
323 | 391 | 2bay (A) | 1 | 55 | 20.00 | 0 | 0.49 | 0.12 | -0.31 |
144 | 177 | 2pne (A) | 30 | 66 | 59.00 | 0.01 | 0.63 | 0.630327 | 0.13 |
304 | 407 | 1wgm (A) | 4 | 93 | 19.00 | 0 | 1 | 0.392859 | -0.21 |
315 | 399 | 3lrq (A) | 5 | 76 | 29.00 | 0 | 1 | 0.484517 | -0.79 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127188)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G47430 | DWNN domain, a CCHC-type zinc finger |
Arabidopsis thaliana | AT4G17410 | DWNN domain-containing protein |
Babesia bovis | BBOV_III006140 | conserved hypothetical protein |
Brugia malayi | Bm1_30420 | Zinc knuckle family protein |
Candida albicans | CaO19.4628 | poss. member of chaperonin-cont. T-complex |
Candida albicans | CaO19.12098 | poss. member of chaperonin-cont. T-complex |
Caenorhabditis elegans | CELE_F36F2.3 | Protein TAG-214, isoform B |
Cryptosporidium hominis | Chro.80429 | development protein DG1124 |
Cryptosporidium parvum | cgd8_3720 | D441/Mpe1p like protein with a zinc knuckle (C2HC) and PhD Zn finger domain |
Dictyostelium discoideum | DDB_G0279003 | hypothetical protein |
Drosophila melanogaster | Dmel_CG3231 | something that sticks like glue |
Echinococcus granulosus | EgrG_000776200 | retinoblastoma binding protein |
Entamoeba histolytica | EHI_014000 | Retinoblatoma-binding protein 6, putative |
Echinococcus multilocularis | EmuJ_000776200 | retinoblastoma binding protein |
Homo sapiens | ENSG00000122257 | retinoblastoma binding protein 6 |
Leishmania braziliensis | LbrM.34.2960 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_353100.1 | nucleic acid binding protein, putative |
Leishmania infantum | LinJ.35.3100 | hypothetical protein, conserved |
Leishmania major | LmjF.35.3050 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.3050 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_04740 | hypothetical protein |
Mus musculus | ENSMUSG00000030779 | retinoblastoma binding protein 6 |
Neospora caninum | NCLIV_062930 | hypothetical protein |
Oryza sativa | 4348695 | Os10g0431000 |
Oryza sativa | 4333626 | Os03g0659400 |
Oryza sativa | 4332754 | Os03g0335100 |
Plasmodium berghei | PBANKA_1028600 | conserved Plasmodium protein, unknown function |
Plasmodium falciparum | PF3D7_1414100 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_1344000 | hypothetical protein, conserved in Apicomplexan species |
Plasmodium vivax | PVX_085745 | hypothetical protein, conserved |
Plasmodium yoelii | PY03290 | development protein DG1124 |
Saccharomyces cerevisiae | YKL059C | Mpe1p |
Schistosoma japonicum | Sjp_0084270 | Retinoblastoma-binding protein 6, putative |
Schistosoma mansoni | Smp_039640.2 | retinoblastoma binding protein |
Schistosoma mansoni | Smp_039640.1 | retinoblastoma binding protein |
Schmidtea mediterranea | mk4.005912.04 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.002560.01 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.006467.01 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.001379.02 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.002373.04 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.002373.05 | |
Schmidtea mediterranea | mk4.017734.00 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.001800.00 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.000457.06 | |
Schmidtea mediterranea | mk4.001379.03 | E3 ubiquitin-protein ligase RBBP6 |
Schmidtea mediterranea | mk4.002032.00 | E3 ubiquitin-protein ligase RBBP6 |
Trypanosoma brucei gambiense | Tbg972.9.7730 | nucleic acid binding protein, putative,predicted zinc finger protein |
Trypanosoma brucei | Tb927.9.12670 | predicted zinc finger protein |
Trypanosoma congolense | TcIL3000_9_5220 | predicted zinc finger protein |
Trypanosoma cruzi | TcCLB.510743.20 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.510659.279 | nucleic acid binding protein, putative |
Toxoplasma gondii | TGME49_245660 | hypothetical protein |
Theileria parva | TP02_0349 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.3620 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.3620 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.3620 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb09.211.3620 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F36F2.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
YKL059C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_245660 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.